Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents

被引:10
|
作者
Itriyeva, Khalida [1 ,2 ]
机构
[1] Northwell Hlth, Div Adolescent Med, Cohen Childrens Med Ctr, New Hyde Pk, NY USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA
关键词
ADULT WOMENS KNOWLEDGE; BONE-MINERAL DENSITY; MEDROXYPROGESTERONE ACETATE; INTRAUTERINE-DEVICE; YOUNG-WOMEN; WEIGHT-GAIN; INNER-CITY; CONTINUATION; IMPLANTS; FAILURE;
D O I
10.1016/j.cppeds.2018.11.002
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The intrauterine devices (IUDs) and the subdermal implant, collectively known as long-acting reversible contraceptives (LARC), along with the Depo-Provera shot, represent highly efficacious methods of birth control for all reproductive-age women, including adolescents. They are also safe, private, and convenient, and can be used for their noncontraceptive benefits. Additionally, LARC and Depo-Provera represent methods of contraception that do not contain estrogen and may be safely used in young women who have contraindications to estrogen-containing medications. The LARC methods have traditionally been underused by adolescents due to lack of knowledge and misperceptions about safety and effects on future fertility. How-ever, studies have found that when barriers to the use of LARC are removed, adolescents have increasingly chosen the IUD and implant for birth control and most continue to use these methods with satisfaction. This chapter will provide an over-view of IUDs, the subdermal implant and Depo-Provera, address barriers to care for adolescents, efficacy, continuation rates, common side effects and reasons for discontinuation, contraindications, and noncontraceptive benefits.
引用
收藏
页码:321 / 332
页数:12
相关论文
共 50 条
  • [21] Preconception counselling at long-acting reversible contraception (LARC) removals
    Blake, Georgina
    Thomas, Helen
    Stephenson, Judith M.
    D'Souza, Rachel
    Hall, Jennifer Anne
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024,
  • [22] Experience with Depo-Provera in adolescents.
    Siqueira, L
    Swedler, J
    Gertner, M
    JOURNAL OF ADOLESCENT HEALTH, 1996, 18 (02) : 132 - 132
  • [23] LONG-TERM CONTRACEPTION WITH DEPO-PROVERA - A CLINICAL-EVALUATION
    MUKHERJEA, M
    MUKHERJEE, P
    BISWAS, R
    INTERNATIONAL JOURNAL OF FERTILITY, 1980, 25 (02) : 122 - 126
  • [24] Computerized tracking of adolescents on Depo-Provera
    Feroli, K
    Pain, J
    Felice, ME
    Beck, C
    JOURNAL OF ADOLESCENT HEALTH, 1998, 22 (02) : 173 - 173
  • [25] Adolescents' Intention to Use Long-Acting Reversible Contraception Postpartum
    Madorsky, Toni Z.
    Stritzel, Haley
    Sheeder, Jeanelle
    Maslowsky, Julie
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2024, 37 (05) : 510 - 515
  • [26] Long-Acting Reversible Contraception for Adolescents A Review
    Francis, Jenny K. R.
    Gold, Melanie A.
    JAMA PEDIATRICS, 2017, 171 (07) : 694 - 701
  • [27] Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes
    Kaneshiro, Bliss
    Salcedo, Jennifer
    CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2015, 4 (01): : 53 - 60
  • [28] Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes
    Bliss Kaneshiro
    Jennifer Salcedo
    Current Obstetrics and Gynecology Reports, 2015, 4 (1) : 53 - 60
  • [29] Patient perception of immediate postpartum long-acting reversible contraception (LARC)
    Sznajder, K. K.
    Carvajal, D. N.
    Sufrin, C.
    CONTRACEPTION, 2017, 96 (04) : 288 - 288
  • [30] Uptake of long-acting reversible contraception (LARC) after termination of pregnancy
    Basu, D.
    Oo, T.
    Kwang, P. Y.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 128 : 29 - 29